JGHHY yields 3.78% · PFE yields 6.13%● Live data
📍 JGHHY pulled ahead of the other in Year 1
Combined, JGHHY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JGHHY + PFE for your $10,000?
Jungheinrich Aktiengesellschaft, through its subsidiaries, manufactures and supplies products and solutions in the fields of warehousing and material handling equipment, automated systems, digital solutions, and matching services worldwide. It operates through Intralogistics and Financial Services segments. The Intralogistics segment develops, produces, sells, and rents new material handling equipment and warehousing equipment products; sale and short-term leasing of used trucks; and provides spare parts, as well as maintenance and repair services. The Financial Services segment engages in the sales financing and usage transfer of material handling and warehousing equipment products. The company's products portfolio includes pedestrian trucks, horizontal and vertical level order pickers, narrow aisle trucks, automated guided vehicles, stacker cranes, load handling equipment, reach trucks, stackers, tow tractors, low lift and double decker trucks, and electric drive trains, as well as pallet trucks; counterbalanced trucks; small-series and customized trucks; powertrain solutions; and electronic control units, lithium-ion batteries, and chargers. It also develops and distributes warehouse and fleet management systems, steering softwares for conveyor systems, and other digital solutions, as well as automation systems; and develops software solutions. The company distributes its products through its direct sales and service network, as well as through dealers. Jungheinrich Aktiengesellschaft was founded in 1953 and is headquartered in Hamburg, Germany.
Full JGHHY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.